Order Article Reprints

Deguchi T, Maekawa N, Konnai S, Owaki R, Hosoya K, Morishita K, Nakamura M, Okagawa T, Takeuchi H, Kim S, et al. Enhanced Systemic Antitumour Immunity by Hypofractionated Radiotherapy and Anti-PD-L1 Therapy in Dogs with Pulmonary Metastatic Oral Malignant Melanoma. Cancers. 2023; 15(11):3013. https://doi.org/10.3390/cancers15113013

Deguchi, Tatsuya, Naoya Maekawa, Satoru Konnai, Ryo Owaki, Kenji Hosoya, Keitaro Morishita, Motoji Nakamura, Tomohiro Okagawa, Hiroto Takeuchi, Sangho Kim, and et al. 2023. "Enhanced Systemic Antitumour Immunity by Hypofractionated Radiotherapy and Anti-PD-L1 Therapy in Dogs with Pulmonary Metastatic Oral Malignant Melanoma" Cancers 15, no. 11: 3013. https://doi.org/10.3390/cancers15113013

Deguchi, T., Maekawa, N., Konnai, S., Owaki, R., Hosoya, K., Morishita, K., Nakamura, M., Okagawa, T., Takeuchi, H., Kim, S., Kinoshita, R., Tachibana, Y., Yokokawa, M., Takagi, S., Kato, Y., Suzuki, Y., Murata, S., & Ohashi, K. (2023). Enhanced Systemic Antitumour Immunity by Hypofractionated Radiotherapy and Anti-PD-L1 Therapy in Dogs with Pulmonary Metastatic Oral Malignant Melanoma. Cancers, 15(11), 3013. https://doi.org/10.3390/cancers15113013